In-utero exposure to antibiotics and risk of colorectal cancer in a prospective cohort of 18 000 adult offspring
- 24 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 52 (5) , 1448-1458
Abstract
Incidence rates of colorectal cancer (CRC) are increasing among younger adults and in mid-life, implicating exposures in early life as risk factors. We examined the association between in-utero exposure to antibiotics and risk of CRC in adult offspring. The Child Health and Development Studies is a prospective cohort of women receiving prenatal care between 1959 and 1966 in Oakland, California, with deliveries through June 1967. Diagnosed conditions and all prescribed medications were abstracted from mothers’ medical records beginning 6 months prior to pregnancy through delivery. We identified mothers who received antibiotics in pregnancy, including penicillins, tetracyclines, short-acting sulfonamides and long-acting sulfonamides. Diagnoses of CRC in adult (age ≥18 years) offspring were ascertained through 2021 by linkage with the California Cancer Registry. Cox proportional models were used to estimate adjusted hazard ratios (aHR), with follow-up accrued from birth through cancer diagnosis, death or last contact. Of 18 751 liveborn offspring, about 15% (n = 2635) were exposed in utero to antibiotics: 5.4% (n = 1016) to tetracyclines, 4.9% (n = 918) to penicillins, 4.2% (n = 785) to short-acting sulfonamides and 1.5% (n = 273) to long-acting sulfonamides. Compared with offspring not exposed, associations between in-utero exposure and CRC in adult offspring were: aHR 1.03 (95% CI 0.32, 3.31) for tetracyclines; aHR 1.12 (95% CI 0.35, 3.58) for penicillins; aHR 0.83 (95% CI 0.20, 3.42) for short-acting sulfonamides; and aHR 4.40 (95% CI 1.63, 11.88) for long-acting sulfonamides. Our findings support an association between in-utero exposure to long-acting sulfonamides and CRC in adulthood.Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health (R01CA242558)
- National Institute of Child Health and Development
- National Institutes of Health (HHSN275201100020C)
- California Department of Public Health
- California Health and Safety Code Section (103885)
- National Cancer Institute’s Surveillance, Epidemiology, and End Results Program (HHSN261201000140C)
- Cancer Prevention Institute of California (HHSN261201000035C)
- University of Southern California (HHSN261201000034C)
- Public Health Institute
- Centers for Disease Control and Prevention’s National Program of Cancer Registries (U58DP003862-01)
- California Department of Public Health
This publication has 49 references indexed in Scilit:
- Challenges and opportunities in research on early-life events/exposures and cancer development later in lifeCancer Causes & Control, 2012
- Doxycycline and sulfadimethoxine transfer from cross-contaminated feed to chicken tissuesFood Additives & Contaminants: Part A, 2011
- Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformationsBritish Journal of Clinical Pharmacology, 2009
- Prenatal Multivitamin Supplementation and Rates of Pediatric Cancers: A Meta-AnalysisClinical Pharmacology & Therapeutics, 2007
- Gene–nutrient interactions: importance of folates and retinoids during early embryogenesisToxicology and Applied Pharmacology, 2004
- Antibiotics and Other Anti-infective Agents in Pregnancy and LactationAmerican Journal of Perinatology, 2003
- Sulphonamide residues in eggs following drug administration via the drinking waterFood Additives & Contaminants, 2002
- Identifiability and Exchangeability for Direct and Indirect EffectsEpidemiology, 1992
- The California Child Health and Development Studies of the School of Public Health, University of California at Berkeley*Paediatric and Perinatal Epidemiology, 1988
- Drugs and Folate MetabolismDrugs, 1985